Skinvisible (SKVI) Ratios
Skinvisible Ratios
SKVI's free cash flow for Q2 2026 was $2.16K. For the 2026 fiscal year, SKVI's free cash flow was increased by $0.00 and operating cash flow was $2.16K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| Quick Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Solvency Ratio | -0.10 | -0.06 | -0.26 | -0.32 | -0.40 |
| Operating Cash Flow Ratio | -0.01 | -0.02 | -0.02 | 0.01 | 0.12 |
| Short-Term Operating Cash Flow Coverage | -0.11 | -5.23 | -0.16 | 0.10 | 0.75 |
| Net Current Asset Value | $ -10.36M | $ -9.36M | $ -9.15M | $ -6.78M | $ -5.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 44.87 | 36.27 | 37.78 | 15.06 | 13.56 |
| Debt-to-Equity Ratio | -0.56 | -0.62 | -0.68 | -0.56 | -0.57 |
| Debt-to-Capital Ratio | -1.26 | -1.64 | -2.14 | -1.27 | -1.32 |
| Long-Term Debt-to-Capital Ratio | -1.10 | -1.63 | -1.69 | -0.95 | -0.91 |
| Financial Leverage Ratio | -0.01 | -0.02 | -0.02 | -0.04 | -0.04 |
| Debt Service Coverage Ratio | -0.51 | 0.18 | -0.20 | -0.03 | 0.12 |
| Interest Coverage Ratio | -0.87 | -0.88 | -0.26 | -0.21 | 0.16 |
| Debt to Market Cap | 4.60 | 3.36 | 16.18 | 8.10 | 2.83 |
| Interest Debt Per Share | 1.17 | 1.27 | 1.77 | 1.07 | 0.95 |
| Net Debt to EBITDA | -12.13 | 46.11 | -12.91 | -83.98 | 14.64 |
| Profitability Margins | |||||
| Gross Profit Margin | -1.20% | -2.19% | 100.00% | 98.28% | 99.50% |
| EBIT Margin | -2458.93% | 518.92% | -2476.45% | -22.21% | 28.35% |
| EBITDA Margin | -2357.73% | 621.11% | -2382.59% | -15.50% | 31.05% |
| Operating Profit Margin | -2481.58% | -2947.95% | -2451.88% | -85.37% | 28.35% |
| Pretax Profit Margin | -5320.17% | -2828.27% | -11912.20% | -438.56% | -161.70% |
| Net Profit Margin | -5320.17% | -2828.27% | -11912.20% | -791.76% | -344.54% |
| Continuous Operations Profit Margin | -5320.17% | -2828.27% | -11912.20% | -438.56% | -161.70% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 180.53% | 213.08% |
| EBT Per EBIT | 214.39% | 95.94% | 485.84% | 513.73% | -570.37% |
| Return on Assets (ROA) | -834.10% | -357.52% | -1462.80% | -896.03% | -1005.63% |
| Return on Equity (ROE) | 10.37% | 6.12% | 26.40% | 33.30% | 42.21% |
| Return on Capital Employed (ROCE) | 10.15% | 16.74% | 14.64% | 7.02% | -6.64% |
| Return on Invested Capital (ROIC) | 10.94% | 16.81% | 17.09% | 8.15% | -8.06% |
| Return on Tangible Assets | -3864.86% | -1345.90% | -6718.67% | -2011.30% | -3078.76% |
| Earnings Yield | -85.54% | -33.16% | -626.61% | -481.80% | -209.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.89 | 0.89 | 0.75 | 14.64 | 8090.56 |
| Payables Turnover | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.16 | 0.13 | 0.12 | 1.13 | 2.92 |
| Working Capital Turnover Ratio | -0.00 | -0.01 | -0.01 | -0.09 | -0.23 |
| Cash Conversion Cycle | -22196.97 | -14928.36 | 485.30 | -91220.29 | -114992.76 |
| Days of Sales Outstanding | 412.30 | 412.30 | 485.30 | 24.93 | 0.05 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 22609.28 | 15340.66 | 0.00 | 91245.22 | 114992.81 |
| Operating Cycle | 412.30 | 412.30 | 485.30 | 24.93 | 0.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.02 | 0.01 | 0.08 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | 0.01 | 0.08 |
| Dividend Paid and CapEx Coverage Ratio | -9.40 | -7.58 | -8.27 | 17.85 | 17.95 |
| Capital Expenditure Coverage Ratio | -9.40 | -7.58 | -8.27 | 17.85 | 17.95 |
| Operating Cash Flow Coverage Ratio | -0.01 | -0.01 | -0.01 | 0.01 | 0.12 |
| Operating Cash Flow to Sales Ratio | -1.92 | -3.49 | -3.86 | 0.16 | 0.56 |
| Free Cash Flow Yield | -3.42% | -4.63% | -22.75% | 9.29% | 32.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.15 | -3.06 | -0.16 | -0.21 | -0.48 |
| Price-to-Sales (P/S) Ratio | 62.19 | 85.28 | 19.01 | 1.64 | 1.64 |
| Price-to-Book (P/B) Ratio | -0.12 | -0.18 | -0.04 | -0.07 | -0.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.27 | -21.58 | -4.40 | 10.76 | 3.08 |
| Price-to-Operating Cash Flow Ratio | -32.38 | -24.42 | -4.93 | 10.16 | 2.91 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.04 | -0.03 | 0.10 | 0.03 |
| Enterprise Value Multiple | -14.77 | 59.84 | -13.71 | -94.58 | 19.93 |
| Enterprise Value | 6.97M | 7.43M | 6.53M | 4.09M | 4.11M |
| EV to EBITDA | -14.77 | 59.84 | -13.71 | -94.58 | 19.93 |
| EV to Sales | 348.29 | 371.66 | 326.62 | 14.66 | 6.19 |
| EV to Free Cash Flow | -163.91 | -94.03 | -75.53 | 96.00 | 11.61 |
| EV to Operating Cash Flow | -181.35 | -106.44 | -84.66 | 90.63 | 10.96 |
| Tangible Book Value Per Share | -1.92 | -1.85 | -2.02 | -1.49 | -1.23 |
| Shareholders’ Equity Per Share | -1.90 | -1.83 | -1.99 | -1.46 | -1.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.06 | 0.15 |
| Net Income Per Share | -0.20 | -0.11 | -0.52 | -0.49 | -0.50 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.81 | 2.13 |
| Interest Burden | 2.16 | -5.45 | 4.81 | 19.75 | -5.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 24803800.00 | 29.46 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.04 | 0.12 | 0.03 | -0.04 | -0.35 |
Currency in USD
